KeyBank National Association
CYTO

KeyBank National Association’s Altamira Therapeutics Ltd CYTO Stock Holding History

KeyBank National Association’s Portfolio CYTO Stock Details CYTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Hold
0
– -$14K – 1116
2017
Q3 		– Hold
0
– – – 1101
2017
Q2 		– Hold
0
– – – 1102
2017
Q1 		– Hold
0
– – – 1136
2016
Q4 		– Hold
0
– – – 1139
2016
Q3 		– Sell
-1
Closed -$238K – 1144
2016
Q2 		$183K Hold
1
– – ﹤0.01% 1051
2016
Q1 		$159K Hold
1
– – ﹤0.01% 1054
2015
Q4 		$214K Buy
+1
New +$288K ﹤0.01% 1044
2015
Q3 		– Hold
0
– – – 1105
2015
Q2 		– Hold
0
– – – 1167

Other funds holding CYTO

SMV
Sofinnova Management VIII Menlo Park, California $183M AUM 4.18% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

KeyBank National Association's CYTO Position: Q4 2017 in Review

KeyBank National Association held its Altamira Therapeutics Ltd (CYTO) position steady in Q4 2017 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1116.

KeyBank National Association first reported a position in CYTO in Q4 2015 and has held it in 3 quarters since. The position peaked at $214K in Q4 2015. 8 funds tracked by Wall St. Rank hold CYTO as of Q4 2017.

  • KeyBank National Association held 0 shares of Altamira Therapeutics Ltd worth $0 as of Q4 2017.
  • KeyBank National Association left its Altamira Therapeutics Ltd share count unchanged in Q4 2017.
  • Altamira Therapeutics Ltd made up ﹤0.01% of KeyBank National Association's portfolio in Q4 2017, its #1116 holding.
  • KeyBank National Association first reported a position in Altamira Therapeutics Ltd in Q4 2015 and has held it in 3 quarters since.
  • KeyBank National Association's Altamira Therapeutics Ltd position peaked at $214K in Q4 2015.
  • 8 funds tracked by Wall St. Rank held Altamira Therapeutics Ltd as of Q4 2017.

Based on KeyBank National Association's 13F filing for Q4 2017, filed 8 Feb 2018.